Zeitlich begrenzter Therapieversuch („time-limited trial“, TLT) auf der Intensivstation
Susanne Jöbges, Anna‐Henrikje Seidlein, Kathrin Knochel, Andrej Michalsen, Gunnar Duttge, Alexander Supady, Jochen Dutzmann, Stefan Meier, Iris Barndt, Gerald Neitzke, Friedemann Nauck, Annette Rogge, Uwe Janssens
Abstract
The rise in intensive care treatment procedures is accompanied by an increase in the complexity of decisions regarding the selection, administration and duration of treatment measures. Whether a treatment goal is desirable in an individual case and the treatment plan required to achieve it is acceptable for the patient depends on the patient's preferences, values and life plans. There is often uncertainty as to whether a patient-centered treatment goal can be achieved. The use of a time-limited treatment trial (TLT) as a binding agreement between the intensive care unit (ICU) team and the patient or their legal representative on a treatment concept over a defined period of time in the ICU can be helpful to reduce uncertainties and to ensure the continuation of intensive care measures in the patients' best interest.